Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Cardiovascular events in cancer survivors.

Howard E, Steingart RM, Armstrong GT, Lyon AR, Armenian SH, Teresa Voso M, Cicconi L, Coco FL, Minotti G.

Semin Oncol. 2019 Dec;46(6):426-432. doi: 10.1053/j.seminoncol.2019.01.007. Epub 2019 Nov 19. Review.

PMID:
31791551
2.

Clinical characteristics and treatment outcome of an 86-year-old patient with acute myeloid leukaemia with acute promyelocytic-like morphology and uncommon RARA fusion variant.

Castelli R, Rossi V, Della Porta MG, Schiavon R, Barchiesi M, Cicconi L, Coco FL.

Ann Hematol. 2018 Dec;97(12):2523-2525. doi: 10.1007/s00277-018-3377-7. Epub 2018 Jun 5. No abstract available.

PMID:
29872883
3.

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.

Sanarico AG, Ronchini C, Croce A, Memmi EM, Cammarata UA, De Antoni A, Lavorgna S, Divona M, Giacò L, Melloni GEM, Brendolan A, Simonetti G, Martinelli G, Mancuso P, Bertolini F, Coco FL, Melino G, Pelicci PG, Bernassola F.

Leukemia. 2018 Apr;32(4):911-919. doi: 10.1038/leu.2017.342. Epub 2017 Dec 6.

4.

Simple, rapid and accurate molecular diagnosis of acute promyelocytic leukemia by loop mediated amplification technology.

Spinelli O, Rambaldi A, Rigo F, Zanghì P, D'Agostini E, Amicarelli G, Colotta F, Divona M, Ciardi C, Coco FL, Minnucci G.

Oncoscience. 2014 Dec 27;2(1):50-8. eCollection 2015.

5.

Molecular pathogenesis of secondary acute promyelocytic leukemia.

Joannides M, Mays AN, Mistry AR, Hasan SK, Reiter A, Wiemels JL, Felix CA, Coco FL, Osheroff N, Solomon E, Grimwade D.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011045. doi: 10.4084/MJHID.2011.045. Epub 2011 Oct 24.

6.

Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.

Trubia M, Albano F, Cavazzini F, Cambrin GR, Quarta G, Fabbiano F, Ciambelli F, Magro D, Hernandezo JM, Mancini M, Diverio D, Pelicci PG, Coco FL, Mecucci C, Specchia G, Rocchi M, Liso V, Castoldi G, Cuneo A.

Leukemia. 2006 Jan;20(1):48-54.

PMID:
16619048
7.

Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML.

Falini B, Bigerna B, Pucciarini A, Tiacci E, Mecucci C, Morris SW, Bolli N, Rosati R, Hanissian S, Ma Z, Sun Y, Colombo E, Arber DA, Pacini R, La Starza R, Verducci Galletti B, Liso A, Martelli MP, Diverio D, Pelicci PG, Lo Coco F, Martelli MF.

Leukemia. 2006 Feb;20(2):368-71. No abstract available. Erratum in: Leukemia. 2006 Jul;20(7):1330. Coco, FL [corrected to Lo Coco, F]; Galletti, BV [corrected to Verducci Galletti, B].

PMID:
16341033
8.

Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.

Meani N, Minardi S, Licciulli S, Gelmetti V, Coco FL, Nervi C, Pelicci PG, Müller H, Alcalay M.

Oncogene. 2005 May 5;24(20):3358-68.

PMID:
15735696
9.

Imatinib-mesylate for all patients with hypereosinophilic syndrome?

Musto P, Perla G, Minervini MM, Carella AM, Coco FL, Catalano G.

Leuk Res. 2004 Jul;28(7):773-4. No abstract available.

PMID:
15158099
10.

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation.

Venditti A, Maurillo L, Buccisano F, Del Poeta G, Mazzone C, Tamburini A, Del Principe MI, Consalvo MI, De Fabritiis P, Cudillo L, Picardi A, Franchi A, Lo-Coco F, Amadori S.

Leukemia. 2003 Nov;17(11):2178-82. Erratum in: Leukemia. 2004 Feb;18(2):373. Coco FL [corrected to Lo-Coco F].

PMID:
14576731
11.

Different mechanisms lead to a karyotypically identical t(20;21) in myelodysplastic syndrome and in acute myelocytic leukemia.

Matteucci C, La Starza R, Crescenzi B, Romoli S, Santoro A, Magrin S, Lauria F, Coco FL, Martelli MF, Mecucci C.

Cancer Genet Cytogenet. 2003 Jan 1;140(1):13-7.

PMID:
12550752
12.

Analysis of the PML/RAR-α Fusion Gene in Acute Promyelocytic Leukemia by Reverse-Transcription Polymerase Chain Reaction : Technical Recommendations, Advantages, and Pitfalls.

Diverio D, Luciano A, Riccioni R, Coco FL, Biondi A.

Methods Mol Med. 1996;6:47-54. doi: 10.1385/0-89603-341-4:47.

PMID:
21380696

Supplemental Content

Support Center